Tumor Ablation Market Size, Share will reach 1.9 billion USD by the end of 2025

Market Study Report Provides A Detailed Overview Of Tumor Ablation Market With Respect To The Pivotal Drivers Influencing The Revenue Graph Of This Business Sphere.

Delaware, Selbyville - November 15, 2019 /MarketersMedia/ —

The global Tumor Ablation Market is anticipated to reach USD 1.9 billion by 2025 according to a new study.

Request a sample of this premium report titled at: https://www.marketstudyreport.com/request-a-sample/1695084?utm_source=marketersmedia.com&utm_medium=ADS

Ablation is treatment for the destruction of liver tumors without removing them. These technique is used in patients with few small tumors and when surgery is not a worthy option due to reduced liver function or poor health condition. These treatment is sometimes used in patients waiting for a liver transplant. Generally, tumor ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to freeze or burn cancers without the surgery. Ultrasound (US), Computed Tomography (CT), or Magnetic Resonance Imaging (MRI) are used to guide and position the needle probe into the tumor. The most common cancers treated by this method are lung cancer, liver cancer and kidney (renal) cancer. Other cancers can also be treated if the tumor cell are accessible to reach and of appropriate size

On the basis of the type of technology, the global tumor ablation market is further categorized into surgical ablation, laparoscopic ablation, and percutaneous ablation. Moreover, on the basis of application the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, and others. Lung cancer is anticipated to grow with the fastest rate in the forecast period due to growing prevalence of lung cancer cases and increasing private as well as government investment to develop new lung cancer ablation products.

With the increasing geriatric population, the demand for minimally invasive surgeries (MIS) is increasing globally. Through minimally intrusive surgeries, the patients result in faster recovery in comparison to conventional invasive procedures. Therefore, the demand for minimally invasive procedures such as radiofrequency ablation and cryoablation is increasing and thereby augmenting the global market growth.

The global tumor ablation market is segmented on the basis of type of technology, mode of treatment, and application. On the basis of type of technology, the global tumor ablation market is segmented into Radiofrequency (RF) ablation, Microwave ablation, Cryoablation, and others. The radiofrequency ablation is estimated to dominate the global tumor ablation market owing to its design of treating target tissues without causing damage to the surrounding healthy cells. However, microwave ablation technology is expected to grow at the rapid test rate in the upcoming years, due to increasing adoption of microwave tumor ablation among healthcare specialists.

The global tumor ablation market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of tumor ablation for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional or traditional surgical procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the continual developments in ablation expertise, leading to the increased development of new and pioneering products that are the efficient, safe, and minimally invasive are also advancing towards significant growth of the global tumor ablation market.

Some of the key players operating in global tumor ablation market are EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp., BTG International Ltd., Integra LifeSciences Holdings Corp., and Medtronic plc. among others.

Request a discount on standard prices of this premium report titled at: https://www.marketstudyreport.com/check-for-discount/1695084?utm_source=marketersmedia.com&utm_medium=ADS

Table of Contents:

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Tumor Ablation Market Insights
3.1. Tumor ablation? Industry snapshot
3.2. Tumor ablation -Ecosystem analysis
3.3. Tumor ablation market dynamics
3.3.3. Tumor ablation market PEST analysis, 2017
3.3.4. Value Chain Analysis
3.3.5. Tumor ablation Industry trends
3.3.6. Prevalence of tumor ablation
4. Tumor ablation Market Size and Forecast by type of technology
4.1. Key findings
4.2. Radiofrequency (RF) ablation
4.5.1. Global market estimates and forecasts, 2017 ? 2025
5. Tumor ablation Market Size and Forecast by Mode of treatment
5.1. Key findings
5.2. Surgical ablation
5.2.1. Global market estimates and forecasts, 2017 ? 2025
5.3. Laparoscopic ablation
5.3.1. Global market estimates and forecasts, 2017 ? 2025
5.4. Percutaneous ablation
5.4.1. Global market estimates and forecasts, 2017 ? 2025
6. Tumor ablation Market Size and Forecast by Application
6.1. Key findings
7. Tumor ablation Market Size and Forecast by Regions

Questions? Get them answered via https://www.marketstudyreport.com/enquiry-before-buying/1695084?utm_source=marketersmedia.com&utm_medium=ADS before taking a buying decision on this premium report titled Global Tumor Ablation Market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com

Source URL: https://marketersmedia.com/tumor-ablation-market-size-share-will-reach-19-billion-usd-by-the-end-of-2025/88934440

Source: MarketersMedia

Release ID: 88934440

More News From walkthebiz.com

Europe's specialty food makers brace for US tariffs

Dec 9, 2019

MILAN — European producers of premium specialty agricultural products like French wine, Italian Parmesan and Spanish olives are facing a U.S. tariff hike due Friday with a mix of trepidation and indignation at being dragged into a trade war they feel they have little to do with. The tariffs on $7.5 billion on a range of European goods were approved by the World Trade Organization as compensation for illegal EU subsidies to plane maker Airbus. The U.S. has some leeway in deciding what goods it puts tariffs on. So while it is taxing European aircraft goods an extra 10%, it...

The Latest: Pence heads to Mideast as Turkey attacks Kurds

Dec 9, 2019

WASHINGTON — The Latest on the United States and the military withdrawal from northern Syria (all times local): 6:20 p.m. Vice President Mike Pence says he's being dispatched to the Middle East by President Donald Trump as U.S. troops pull out of northeast Syria and Turkish forces invade. Pence says Trump spoke with Turkish leader Recep Tayyip Erdogan earlier Monday and called for an immediate end to Turkey's moves against the Kurds in Syria. Pence says the president is "very concerned about instability in the region" and is denying that Trump gave Turkey the green light to launch the invasion...

Asian stocks gain after US, China announce truce on tariffs

Dec 9, 2019

BEIJING — Asian stock markets have risen after Washington and Beijing announced a truce on tariff hikes in a trade war. Benchmarks in Shanghai, Hong Kong and Seoul advanced. Japanese markets were closed for a holiday. President Donald Trump agreed Friday to put off planned tariff hikes this week on Chinese goods in a fight over Beijing's trade surplus and technology plans. In exchange, he said China would buy American farm goods. But the two sides reported no progress on basic disputes that sparked the 15-month-old fight that threatens global economic growth. Friday's truce "has simply temporarily halted the escalation...

Impeachment dominates, but much other work awaits Congress

Dec 9, 2019

WASHINGTON — Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators, and they're returning to work this week with mixed hopes of success. It's a difficult-to-predict time when it comes to possible deals between President Donald Trump and House Speaker Nancy Pelosi, who's kicked off the impeachment inquiry. An important trade agreement has a pulse. An effort to deal with prescription drug prices seems stuck. Divided government has produced scant results thus far, except for a small-scale budget deal that lawmakers are struggling to put in place....

Kosovo election winner in no rush to restart Serbia talks

Dec 9, 2019

PRISTINA, Kosovo — A left-wing party leader poised to become Kosovo's next prime minister said Tuesday he isn't in any rush to restart formal talks intended to normalize relations with Serbia and won't lift the previous government's 100% tariff on Serb imports. In a general election held Sunday, Albin Kurti's Movement for Self-the Determination, or Vetevendosje, defeated center-right political groupings formed by former Kosovo Liberation Army fighters who had governed since 2007. Kosovo, a former Serbian province, declared independence in 2008, a decade after an insurrection by KLA fighters and Serbian strongman Slobodan Milosevic's bloody crackdown launched a 1998-99 war....

Walk The Biz welcomes all casual and easygoing readers who seeks to digest business travel to international trade policy to starting in the transportation & shipping industry.

Subscribe to our newsletter now!

Name:

Email: